Oncology & Cancer

Preclinical tests may lead to new approach to treat CNS lymphoma

A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, ...

Medications

Australian wins millions in Thalidomide lawsuit

(AP) — An Australian woman born without arms and legs after her pregnant mother took the anti-morning sickness drug Thalidomide has reached a multimillion dollar settlement with the medicine's British distributor, her ...

Neuroscience

How thalidomide is effective against cerebral infarction

The cause of a major pharmaceutical scandal approximately 60 years ago, thalidomide caused severe birth defects when administered to pregnant women as a remedy for their morning sickness. In recent years, however, thalidomide ...

Medications

Thalidomide class action settled in Australia

A class action over birth defects linked to the morning sickness drug thalidomide was settled in an Australian court Monday, with the British distributor agreeing to pay victims Aus$89 million (US$81 million).

page 3 from 4